Perrigo officially rejects Mylan's 'insulting,' 'ego'-driven buyout offer

Surprise, surprise. Perrigo ($PRGO), which has staunchly opposed suitor Mylan's ($MYL) buyout offers since the company first expressed interest back in April, has officially advised shareholders to shoot down the would-be buyer's proposal. Perrigo believes Mylan's offer is "'not even in the right zip code,' 'trying to steal this company,' 'using fear,' 'insulting,' 'this is about ego,'" Evercore ISI analyst Umer Raffat wrote in a note to clients. Strong language, but "[n]othing dramatically new in my opinion," the analyst said. Release

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.